Cargando…

Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly

Messenger RNA (mRNA) therapeutics have recently demonstrated high clinical potential with the accelerated approval of SARS-CoV-2 vaccines. To fulfill the promise of unprecedented mRNA-based treatments, the development of safe and efficient carriers is still necessary to achieve effective delivery of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenqian, Miyazaki, Takuya, Nakagawa, Yasuhiro, Boonstra, Eger, Masuda, Keita, Nakashima, Yuki, Chen, Pengwen, Mixich, Lucas, Barthelmes, Kevin, Matsumoto, Akira, Mi, Peng, Uchida, Satoshi, Cabral, Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026751/
https://www.ncbi.nlm.nih.gov/pubmed/36950277
http://dx.doi.org/10.1080/14686996.2023.2170164
_version_ 1784909579680743424
author Yang, Wenqian
Miyazaki, Takuya
Nakagawa, Yasuhiro
Boonstra, Eger
Masuda, Keita
Nakashima, Yuki
Chen, Pengwen
Mixich, Lucas
Barthelmes, Kevin
Matsumoto, Akira
Mi, Peng
Uchida, Satoshi
Cabral, Horacio
author_facet Yang, Wenqian
Miyazaki, Takuya
Nakagawa, Yasuhiro
Boonstra, Eger
Masuda, Keita
Nakashima, Yuki
Chen, Pengwen
Mixich, Lucas
Barthelmes, Kevin
Matsumoto, Akira
Mi, Peng
Uchida, Satoshi
Cabral, Horacio
author_sort Yang, Wenqian
collection PubMed
description Messenger RNA (mRNA) therapeutics have recently demonstrated high clinical potential with the accelerated approval of SARS-CoV-2 vaccines. To fulfill the promise of unprecedented mRNA-based treatments, the development of safe and efficient carriers is still necessary to achieve effective delivery of mRNA. Herein, we prepared mRNA-loaded nanocarriers for enhanced in vivo delivery using biocompatible block copolymers having functional amino acid moieties for tunable interaction with mRNA. The block copolymers were based on flexible poly(ethylene glycol)-poly(glycerol) (PEG-PG) modified with glycine (Gly), leucine (Leu) or tyrosine (Tyr) via ester bonds to generate block catiomers. Moreover, the amino acids can be gradually detached from the block copolymers after ester bond hydrolyzation, avoiding cytotoxic effects. When mixed with mRNA, the block catiomers formed narrowly distributed polymeric micelles with high stability and enhanced delivery efficiency. Particularly, the micelles based on tyrosine-modified PEG-PG (PEG-PGTyr), which formed a polyion complex (PIC) and π–π stacking with mRNA, displayed excellent stability against polyanions and promoted mRNA integrity in serum. PEG-PGTyr-based micelles also increased the cellular uptake and the endosomal escape, promoting high protein expression both in vitro and in vivo. Furthermore, the PEG-PGTyr-based micelles significantly extended the half-life of the loaded mRNA after intravenous injection. Our results highlight the potential of PEG-PGTyr-based micelles as safe and effective carriers for mRNA, expediting the rational design of polymeric materials for enhanced mRNA delivery.
format Online
Article
Text
id pubmed-10026751
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-100267512023-03-21 Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly Yang, Wenqian Miyazaki, Takuya Nakagawa, Yasuhiro Boonstra, Eger Masuda, Keita Nakashima, Yuki Chen, Pengwen Mixich, Lucas Barthelmes, Kevin Matsumoto, Akira Mi, Peng Uchida, Satoshi Cabral, Horacio Sci Technol Adv Mater Focus on Frontline Research on Biomaterials-based Bioengineering for Future Therapy Messenger RNA (mRNA) therapeutics have recently demonstrated high clinical potential with the accelerated approval of SARS-CoV-2 vaccines. To fulfill the promise of unprecedented mRNA-based treatments, the development of safe and efficient carriers is still necessary to achieve effective delivery of mRNA. Herein, we prepared mRNA-loaded nanocarriers for enhanced in vivo delivery using biocompatible block copolymers having functional amino acid moieties for tunable interaction with mRNA. The block copolymers were based on flexible poly(ethylene glycol)-poly(glycerol) (PEG-PG) modified with glycine (Gly), leucine (Leu) or tyrosine (Tyr) via ester bonds to generate block catiomers. Moreover, the amino acids can be gradually detached from the block copolymers after ester bond hydrolyzation, avoiding cytotoxic effects. When mixed with mRNA, the block catiomers formed narrowly distributed polymeric micelles with high stability and enhanced delivery efficiency. Particularly, the micelles based on tyrosine-modified PEG-PG (PEG-PGTyr), which formed a polyion complex (PIC) and π–π stacking with mRNA, displayed excellent stability against polyanions and promoted mRNA integrity in serum. PEG-PGTyr-based micelles also increased the cellular uptake and the endosomal escape, promoting high protein expression both in vitro and in vivo. Furthermore, the PEG-PGTyr-based micelles significantly extended the half-life of the loaded mRNA after intravenous injection. Our results highlight the potential of PEG-PGTyr-based micelles as safe and effective carriers for mRNA, expediting the rational design of polymeric materials for enhanced mRNA delivery. Taylor & Francis 2023-03-16 /pmc/articles/PMC10026751/ /pubmed/36950277 http://dx.doi.org/10.1080/14686996.2023.2170164 Text en © 2023 The Author(s). Published by National Institute for Materials Science in partnership with Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Focus on Frontline Research on Biomaterials-based Bioengineering for Future Therapy
Yang, Wenqian
Miyazaki, Takuya
Nakagawa, Yasuhiro
Boonstra, Eger
Masuda, Keita
Nakashima, Yuki
Chen, Pengwen
Mixich, Lucas
Barthelmes, Kevin
Matsumoto, Akira
Mi, Peng
Uchida, Satoshi
Cabral, Horacio
Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title_full Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title_fullStr Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title_full_unstemmed Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title_short Block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mRNA delivery via π–π stacking-assisted micellar assembly
title_sort block catiomers with flanking hydrolyzable tyrosinate groups enhance in vivo mrna delivery via π–π stacking-assisted micellar assembly
topic Focus on Frontline Research on Biomaterials-based Bioengineering for Future Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026751/
https://www.ncbi.nlm.nih.gov/pubmed/36950277
http://dx.doi.org/10.1080/14686996.2023.2170164
work_keys_str_mv AT yangwenqian blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT miyazakitakuya blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT nakagawayasuhiro blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT boonstraeger blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT masudakeita blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT nakashimayuki blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT chenpengwen blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT mixichlucas blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT barthelmeskevin blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT matsumotoakira blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT mipeng blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT uchidasatoshi blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly
AT cabralhoracio blockcatiomerswithflankinghydrolyzabletyrosinategroupsenhanceinvivomrnadeliveryviappstackingassistedmicellarassembly